PRL and in situ carcinoma: Researchers have discovered elevated PRL levels in neuromyelitis optica (NMO) and clinically isolated syndrome (CIS) patients, indicating that altered PRL production is not unique to MS but may be a broader characteristic of autoimmune demyelinating disorders [113].